2984 2984 Pill: blue & white, capsule/oblong
The pill with imprint 2984 2984 (Blue & White, Capsule/Oblong, 0mm) has been identified as Doxycycline Hyclate 50 mg and is used for Actinomycosis, Acne, Amebiasis, Anthrax, and Gonococcal Infection, Uncomplicated. It belongs to the drug classes miscellaneous antimalarials, tetracyclines and is not a controlled substance.
Images for 2984 2984
Doxycycline Hyclate
- Imprint
- 2984 2984
- Strength
- 50 mg
- Color
- Blue & White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Chartwell RX, LLC
- Inactive Ingredients
-
silicon dioxide,
lactose anhydrous,
magnesium stearate,
methylcellulose (400 mPa.s),
microcrystalline cellulose,
polyethylene glycol,
sodium starch glycolate type A potato,
stearic acid,
titanium dioxide,
gelatin,
FD&C Blue No. 1,
D&C Yellow No. 10,
FD&C Blue No. 2,
FD&C Red No. 40,
butyl alcohol,
shellac,
propylene glycol,
alcohol,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 47781-0489 (Discontinued) | Alvogen, Inc. |
| 67253-0388 (Discontinued) | DAVA Pharmaceuticals, Inc. |
| 67405-0650 (Discontinued) | Harris Pharmaceutical, Inc. |
Related images for "2984 2984"
More about doxycycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,642)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antimalarials
- Breastfeeding
- En español
Patient resources
Other brands
Vibramycin, Monodox, Doryx, Doryx MPC, ... +8 more
Professional resources
- Doxycycline monograph
- Doxycycline (Topical) (AHFS Monograph)
- Doxycycline Hyclate (EENT) (AHFS Monograph)
- Doxycycline (FDA)
- Doxycycline Delayed Release Capsule (FDA)
Other brands
Vibramycin, Monodox, Doryx, Oracea, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.